MyAverix Finance
US · Healthcare
Prime Medicine, Inc. Common Stock (PRME)
Biotechnology
Prime Medicine, Inc. Common Stock (PRME) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PRME
Prime Medicine, Inc. Common Stock (PRME) — FAQ
What is PRME's P/E ratio?
The price-to-earnings (P/E) ratio for Prime Medicine, Inc. Common Stock (PRME) is 25.00 (data as of 2026-05-24).
Does Prime Medicine, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Prime Medicine, Inc. Common Stock (PRME). Check the MyAverix Finance app for the latest dividend data.
What sector is Prime Medicine, Inc. Common Stock in?
Prime Medicine, Inc. Common Stock (PRME) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PRME listed on?
PRME is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.